Next Article in Journal
Behavior of Children during Dental Care with Rubber Dam Isolation: A Randomized Controlled Study
Next Article in Special Issue
Abrasion Behaviour of Different Charcoal Toothpastes When Using Electric Toothbrushes
Previous Article in Journal
Accuracy of Guided Surgery and Real-Time Navigation in Temporomandibular Joint Replacement Surgery
Previous Article in Special Issue
The New Normalcy in Dentistry after the COVID-19 Pandemic: An Italian Cross-Sectional Survey
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Dentistry Journal
Volume 9
Issue 8
10.3390/dj9080088
dentistry-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Cariogenic Biofilms: Development, Properties, and Biomimetic Preventive Agents

by
Frederic Meyer
1,*,
Joachim Enax
1,
Matthias Epple
2,
Bennett T. Amaechi
3 and
Barbara Simader
1
1
Research Department, Dr. Kurt Wolff GmbH & Co. KG, Johanneswerkstr. 34-36, 33611 Bielefeld, Germany
2
Inorganic Chemistry and Center for Nanointegration Duisburg-Essen (CeNIDE), University of Duisburg-Essen, Universitaetsstr. 5-7, 45117 Essen, Germany
3
Department of Comprehensive Dentistry, School of Dentistry, University of Texas Health San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
*
Author to whom correspondence should be addressed.
Dent. J. 2021, 9(8), 88; https://0-doi-org.brum.beds.ac.uk/10.3390/dj9080088
Submission received: 12 July 2021 / Revised: 27 July 2021 / Accepted: 28 July 2021 / Published: 3 August 2021
(This article belongs to the Special Issue Feature Papers in Dentistry Journal in 2021)
Versions Notes

Abstract

:
Oral biofilms will build up within minutes after cleaning of the dental hard tissues. While the application of remineralizing agents is a well-known approach to prevent dental caries, modern oral care products offer also additional active agents to maintain oral health. Human saliva contains many different organic and inorganic compounds that help to buffer organic acids produced by cariogenic microorganisms. However, most oral care products only contain remineralizing agents. To improve the benefit of those products, further active ingredients are needed. Books, review articles, and original research papers were included in this narrative review. Putting all these data together, we give an overview of oral biofilms and active compounds used in modern oral care products to interact with them. The special focus is on inorganic compounds and their interaction with oral biofilms. While organic compounds have several limitations (e.g., cell toxicity), inorganic compounds based on calcium and/or phosphate (e.g., sodium bicarbonate, hydroxyapatite, calcium carbonate) offer several advantages when used in oral care products. Calcium release can inhibit demineralization, and the release of hydroxide and phosphate ions might help in the buffering of acids. Therefore, the focus of this review is to summarize the scientific background of further active ingredients that can be used for oral care formulations.

1. Introduction

Biofilms and microorganisms are ubiquitous, and they mostly live as commensals with human beings [1]. However, mutations can occur in every microorganism and also changes in the composition of a biofilm, leading to a shift of a former commensal to a pathogenic-dominated composition [1,2,3,4]. As evolutionary pressure also leads to continuous changes in the characteristics of microorganisms, the co-existence between humans and microorganisms is a steadily developing progress [4]. While previous studies even reported that microbial cells exceed human cells, recent studies show an equilibrium of human and microbial cells [5,6]. Nevertheless, these results represent the importance of microbial cells for humans [5,6].
The oral cavity of man is generally believed to be sterile at birth, but shortly after birth, it becomes colonized by oral microorganisms [7]. From then onward, significant alterations in these microorganisms occurs before (predentate) and after (dentate) tooth eruption. The cariogenic microorganisms, particularly Streptococcus mutans, have been shown to infect the oral cavity of an infant as early as 3 months of birth [7]. Among the oral microorganisms, the major organisms associated with caries in man are (on the genus level), (a) Streptococcus (particularly S. mutans), (b) Lactobacillus, (c) Actinomyces, and more recently emerging (d) Bifidobacteria, as well as (e) Veillonella and (f) Prevotella [8,9]. These organisms possess special characteristics that enable them to adhere well to the tooth surface, produce higher amounts of acid from fermentable sugars than other oral bacterial species, and survive better than other bacteria in an acid environment. Cariogenic biofilms play important roles in the overall health of patients. The development and proliferation of those biofilms can only occur when the teeth are not properly and frequently cleansed using a toothbrush and toothpaste. While oral biofilms develop in every human being, they only become cariogenic when fermentable sugars are consumed. As an end product of the sugar metabolism, acids are produced that dissolve the enamel and dentin [10]. If this process is not controlled, it leads to the manifestation of dental caries. However, biofilm confers several beneficial properties to the patients. Dental plaque biofilm can play a role to promote remineralization and inhibit demineralization by serving as a reservoir for the targeted delivery of active agents to the plaque–tooth interface, to be released during an acidic challenge [11]. Furthermore, biofilm may help to prevent colonization by exogenous, and often pathogenic, microorganisms [12].
The oral cavity is a habitat where certain microorganisms co-exist with human cells as commensals or pathogens. While microorganisms such as bacteria, viruses, fungi, and protozoa are present in the oral cavity, human cells have developed several mechanisms to fight pathogens in the oral cavity [13,14,15,16]. While single-cell microorganisms mostly do not pose any harm, biofilm formation is more crucial for human health, as biofilms can be resistant to antibiotics [17]. Biofilms comprise several microbial species, interacting with each other [14,18,19,20]. This interaction can either positively or negatively influence the biofilm growth. In short, biofilms are a mixture of several microbial species synthetizing EPS (extracellular polymeric substances such as proteins, glycolipids, glycoproteins, and extracellular DNA) that are able to protect the microbial community [1,21]. Biofilms preferably grow where shedding and mechanical forces would not inhibit their formation. In the oral cavity, besides mechanical forces such as toothbrushing and abrasive diet, one of the natural mechanisms that inhibit biofilm growth is the salivary flow and its composition [22,23,24]. Saliva contains organic and inorganic components. Organic compounds such as proteins or enzymes (e.g., lactoferrin and lysozyme) with antimicrobial properties can combat biofilm formation or inhibit the growth of an initial biofilm [25,26,27]. The main inorganic compounds in saliva that interfere with the virulence of biofilms, particularly cariogenic biofilms, are phosphate and bicarbonate ions [28,29,30,31,32,33]. Bicarbonate and phosphate ions in saliva buffer the acids produced from carbohydrates (e.g., sucrose) metabolized by the bacteria in biofilms [29,34,35]. Acid buffering prevents demineralization of the tooth tissues by the acids, thus preventing dental caries development [31]. Furthermore, dietary intake of probiotics has been shown to control oral biofilm formation and growth as well as mitigate against some of the virulence factors of bacteria in the biofilm [8,36,37]. Basically, oral biofilms that lead to dental caries can be controlled to a certain extend with the help of the above mechanisms [28]. However, due to the modern diet and many plaque stagnation niches in the oral habitat, additional measures need to be applied to prevent dental caries and other plaque-associated diseases [38]. It is important to note that active agents used in oral care products need to weaken the virulence or at best disrupt oral biofilms, because plaque-free teeth would not develop dental caries [39]. In addition to using toothbrushes, irrespective of hand brushes, powered oscillating toothbrushes, or powered sonic toothbrushes [24], a straightforward way could be the incorporation of active agents in toothpastes and mouth rinses that will penetrate and retain in the oral niches to prevent biofilm growth, or at least reduce acidic biofilms and its potential to demineralize dental hard tissues [28,30,31,40].
The aim of this review is to give an overview of active ingredients, besides the well-known remineralizing agents such as fluorides or hydroxyapatite that can be incorporated into oral care formulations to modify the cariogenic biofilms.

2. Materials and Methods

The databases “BASE”, “PubMed”, and “SciFinder” were used for the literature search on active compounds used in oral care. Search terms were the following: “Oral care AND/OR active compounds AND/OR biofilm modification”. After screening the 1527 results (by 12 July 2021) from the three databases’ results for eligibility, none of the listed references could be directly classified to oral care products. Consequently, this review is articulated as a narrative review.

3. Results

The formation of biofilms, including oral biofilms, is a continuous process on any surfaces that are in contact with liquid [20]. Dental caries can be prevented in two different ways: (a) inhibition and reduction of cariogenic biofilm development and growth (antimicrobials) [41,42,43,44,45] and/or (b) using agents that can either buffer the microbial acids or reduce the demineralization potential of the microbial acids [31,45,46]. In the oral cavity, biofilm formation starts with the non-specific adhesion of bacteria to the pellicle. The pellicle is a thin layer that contains mostly salivary proteins [47,48]. Mucins and statherins are the main components of the pellicle to which bacteria can adhere [49,50]. Bacterial colonization can be subdivided into early colonization, so-called bridge-colonization, and late colonization [14,51]. Early colonizers (i.e., Streptococcus spp. and Actinomyces spp.) adhere to the pellicle using their surface antigen (a protein called adhesin) to form the initial layer of the biofilm, without the involvement of carbohydrates (so-called initial attachment phase) [13,52,53]. With the intake of a fermentable carbohydrate, the bacteria use its cell-bound and further extracelullar enzymes, mostly glucosyltransferases, to polymerize the glucose into adhesive extracellular carbohydrate polymers called glucan or extracellular polysaccharides (EPS). The bacteria use this adhesive EPS to bind to each other and to the tooth surfaces (so-called colonization phase) [53]. Thus, the biofilm is defined as a population of microorganisms growing on a surface, firmly attached to and enmeshed in an extracellular polysaccharide matrix [54]. As the oral cavity is a habitat for more than 700 different bacterial species, the bacterial colonization is followed by a biofilm growth phase [13,55]. The biofilm itself is a distinct ecosystem where different species and even taxa can positively or negatively influence each other, respectively [14,18,56,57]. Microorganisms can communicate by quorum sensing [57,58]. Quorum sensing is a mechanism where microorganisms produce certain molecules that can induce cell functions (e.g., a motility) in recipient cells when a certain threshold (depending on the bacterial strain and quorum-sensing molecule) has been reached [57,59]. Additionally, the EPS, produced by several microorganisms in biofilms, form a protective surrounding around the microbial colonies [1,17,60]. As the oral cavity is a small microcosm on its own and as the biofilm growth follows the rules of ecological pressure, it follows that when a certain kind of nutrition is available, the microorganisms that are best adapted to this food have an advantage over those that are not. Consequently, biofilms can change their composition and characteristics whenever the respective diet changes [61]. Thus, the biofilm growth phase is referred to as the remodeling phase, which is characterized by early dominance by the genus Streptococcus followed by a shift toward more anaerobic and filamentous flora [53]. Hence, over time, the cariogenic biofilms will change, as cells are dying or changing their properties because of ecological pressure [62].
It is well known that cariogenic biofilms develop and proliferate when the diet is rich in fermentable carbohydrates. The cariogenic microorganisms such as Streptococcus species, especially S. mutans, are very efficient in utilizing sucrose. These microorganisms have two metabolic systems (phosphotransferase (PTS) and proton motive force (pmf) systems) that are self-regulated to optimize glucose uptake with varying concentrations (low or high) of sugar in oral environment [63]. The PTS is a high-affinity sugar uptake mechanism driven by phosphoenol pyruvate (PEP) and operates at neutral pH. It enables the bacteria to take up glucose under low extracellular glucose concentrations. The PMF is a low-affinity sugar uptake system activated by a proton motive force (pmf) that operates at low pH, and it enables glucose uptake under high extracellular glucose concentrations [63]. Biofilm has reduced oxygen capacity, so as a survival mechanism, microorganisms produce their energy via anaerobic glycolysis. Glycolysis leads to the metabolism of glucose to adenosine triphosphate (ATP), which is the energy source for the bacteria cell growth and metabolism [63]. Lactic acids and some other organic acids are produced as the by-products of this glucose metabolism, and they diffuse from the biofilm to the tooth surfaces [64]. The acids cause the demineralization of enamel at a pH ≤ 5.5, which is the critical pH for the dissolution of enamel [65]. When enamel (and dentin) are demineralized, calcium and phosphate ions are released from the tooth tissue [10].
Interestingly, biofilms can imbibe calcium, acting as a calcium source for the reduction of subsequent acid attack [31,66,67]. It is pertinent to mention that the mechanical removal of the oral biofilms through oral hygiene procedures (e.g., toothbrushing) does not remove all dental biofilm from the dental hard tissues [24,68]. Biofilms can remain subgingival, supragingival, approximal, occlusal pits and fissures, and on the mucosa close to the tooth [69]. These residual biofilms also imbibe the active ingredients such as calcium and phosphate from oral care formulations in addition to the products of tooth dissolution. Thus, oral biofilm can play a role to promote remineralization and inhibit demineralization by serving as a reservoir for the targeted delivery of active agents to the plaque–tooth interface, which are released during an acidic challenge [11]. Suffice to say, the active ingredients in oral biofilm interact with the biofilm, changing it from pathogenic to healthy (protective) biofilm.

4. Preventive Measures

4.1. Biomimetic Substances for pH-Buffering in Cariogenic Biofilms

4.1.1. Overview

In addition to mechanical plaque removal with the help of a toothbrush and toothpaste that usually mostly contains antibacterial compounds (e.g., zinc ions) [28,70], another concept can be applied to combat cariogenic biofilms [46,70,71,72,73,74]. Such a strategy uses different basic substances to buffer an acidic plaque pH. An important prerequisite for the use of these substances in oral care formulations such as toothpastes and mouth rinses is their non-toxicity [75]. For example, strong bases such as sodium hydroxide (NaOH) (one molar solution has a pH = 14) should not be used because of their non-physiological pH value and its associated cell toxicity. Oral care formulations should be formulated with a pH range of 6.8–7.4, as this is the physiological pH of saliva [76]. Consequently, to date, there is only a limited number of potential buffering agents that can be used for oral care formulations (Table 1).
In oral care formulations, mainly amino acids (e.g., arginine, C6H14N4O2) [77,78], carbonates (e.g., calcium carbonate, CaCO3) [79,80], and calcium phosphates [29] (e.g., hydroxyapatite, Ca5(PO4)3(OH) [31]), casein phosphopeptide-amorphous calcium phosphate (Cax(PO4)y n · H2O) [81], and α-tricalcium phosphate (α-Ca3(PO4)2) [82] are used as active ingredients to act as a buffer in oral care formulations against cariogenic biofilms.

4.1.2. Organic Substances Used in Oral Care Formulations

Different organic components are known to act as buffer for acids. However, organic systems based on carboxylic acids (R-COOH) or amines (R-NH2) are not suitable for the use as buffering agents in oral care formulations. Their pKa values are either too low (carboxylic acids: 3–5) or too high (amines: 9–11).
Organic compounds that can be used in oral care formulations are amino acids. Amino acids have (at least) one carboxylic acid group and one amino group per molecule. Basic amino acids that may act as buffering agents in cariogenic biofilms are arginine (pKa = 12.48) and lysine (pKa = 10.54). The pH range of buffering is well known to be between pH = 8 and 10, as reported by Fitch et al. [83]. Thus, organic acids that are produced by cariogenic biofilms can principally be buffered by both arginine and lysine. Studies have also shown the buffering effect induced by the arginine metabolism (production of ammonia via the arginine deiminase pathway by certain bacteria) [77,78]. Even though arginine is already used in toothpaste formulations, there are limitations that need to be taken into account. Arginine and other basic amino acids are mostly protonated at pH = 7. This is important because most toothpaste formulations have a pH value around 7; thus, the buffering capacities of arginine are significantly reduced in a toothpaste. From a chemical viewpoint, the pH of such toothpaste formulations should be highly basic, i.e., pH > 10, where arginine could act as buffer for acids (H+ acceptor) [83]. Additionally, arginine is highly soluble in water [84]. This means that the amino acid might be less substantive and can be very quickly washed out from the oral cavity [73]. When used regularly, arginine may cause some unwanted side effects such as diarrhea [85].
Arginine can be seen as prebiotic ingredient in oral care products, as some bacteria are able to metabolize this amino acid, for instance Porphyromonas gingivalis. P. gingivalis is known as a periodontogenic pathogen because it uses arginine via the protein arginine deiminase pathway (PAD) for biofilm formation and the citrullination of arginine. It uses the peptidyl arginine deiminase for the conversion of arginine to citrulline. Citrullination is associated with several multifactorial diseases such as periodontitis or rheumatoid arthritis. Consequently, the addition of arginine to a biofilm with P. gingivalis could lead to an increase in inflammation [56,86].
In addition to pure amino acids, proteins and peptides with free NH2 groups may also have buffering effects. One of those molecules is urea. However, studies have shown a positive correlation between salivary urea concentrations and dental calculus as well as periodontitis [87]. Although arginine can be used to lower the pH of cariogenic biofilms, its use in oral care products should be critically examined due to its potential to increase inflammation.

4.1.3. Inorganic Particles Used in Oral Care Formulations

Solids with buffering effects are, for example, calcium carbonate (buffering effect by carbonate ions) and calcium phosphates (buffering effect by phosphate ions) [29,31,80,82,88]. Shaw et al. have shown that a higher dental plaque calcium content is associated with less dental caries [89]. In the case of calcium carbonate (CaCO3), there are several chemical reactions that can occur under acidic conditions:
  • Reaction of the proton with anions on the solid surface:
2 CaCO3 (s) + 2 H+ (aq) → Ca(HCO3)2 (s) + Ca2+ (aq)
2.
Dissolution of calcium hydrogen carbonate:
Ca(HCO3)2 (s) → Ca2+ (aq) + 2 HCO3− (aq)
3.
Protonation of hydrogen carbonate to carbonic acid:
HCO3− (aq) + H+ → H2CO3 (aq)
4.
Decomposition of carbonic acid into carbon dioxide and water:
H2CO3 (aq) → CO2 (aq) + H2O (l)
5.
Outgassing of carbon dioxide if its solubility is exceeded:
CO2 (aq) → CO2 (g)
All these reactions are equilibrium reactions and generally reversible. They depend mainly on the concentration of the reactants, temperature, and pressure.
In addition to calcium carbonate, hydroxyapatite (Ca5(PO4)3(OH)) can also act as a buffering agent in cariogenic biofilms as reported by Cieplik et al. [31]. Unlike calcium carbonate, the mechanism of the buffering effect of hydroxyapatite is more complex because OH− and PO43− both have buffering effects. A simplified chemical equation for the buffering of acids would be [31]:
Ca5(PO4)3(OH) + 7 H+ → 5 Ca2+ + 3 H2PO4− + H2O
In the case of hydroxyapatite, not only calcium ions will be released but also phosphate ions, both of which contribute to tooth remineralization (unlike in the case of calcium carbonate) [30,31,90]. An important requirement for a buffering effect in cariogenic biofilms is the adhesion of those particles (e.g., hydroxyapatite) to the tooth surface and the incorporation into biofilms as demonstrated in different research studies [41,43,91,92,93,94]. Particulate hydroxyapatite can increase the pH value of cariogenic in vitro biofilms from about 4.3 to 4.8 [31]. Stronger buffering effects can be achieved with carbonated hydroxyapatite or calcium carbonate [88]. Thus, a carbonated hydroxyapatite or a combination of hydroxyapatite/calcium carbonate may not only buffer organic acids but also release calcium and phosphate ions for tooth remineralization [30,90,95,96].
Note that both calcium carbonate and calcium phosphates cannot be formulated with soluble fluoride compounds (e.g., NaF or C27H60F2N2O3 (amine fluoride)) in toothpastes or mouthwashes because of the precipitation of calcium fluoride, CaF2; i.e., an “inactivation” of fluoride would occur under the release of carbonate or hydroxide ions [71,97,98]:
2 F− (aq) + CaCO3 (s) → CaF2 (s) ↓ + CO32− (aq)
and
F− (aq) + Ca5(PO4)3OH (s) → Ca5(PO4)3F (s) + OH− (aq)
However, this is not a limitation for the use of such mineral buffering agents, since recent studies show that fluoride-free toothpastes based on biomimetic hydroxyapatite are not inferior to fluoride toothpastes with regard to remineralization and caries prevention in situ and in vivo [99,100,101]. Additionally, calcium phosphates can be used in caries prevention in small children because they are safe if accidently swallowed and do not induce dental fluorosis or other side effects [75,101]. Unlike soluble active ingredients for oral care applications (e.g., fluorides or cetylpyridinium chloride), mineral particles such as hydroxyapatite can occlude dentin tubules, resulting in a reduction of symptoms of dentin hypersensitivity [30,102,103,104,105,106,107].

4.2. Biomimetic Substances Modifying Bacterial Attachment to Tooth Surfaces

In addition to the release of calcium and phosphate ions and moderate pH-buffering properties in cariogenic biofilms [31], biomimetic hydroxyapatite can significantly reduce bacterial attachment to tooth surfaces without killing bacteria, as demonstrated in in situ studies [41,44]. In contrast, another calcium phosphate, i.e., casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) does not lead to a reduction of initial biofilm formation in situ [81]. Interestingly, fluorides without an antibacterial counterion (NaF, Na2PFO3) do not minimize bacterial colonization [108]. This also supports the applicability of hydroxyapatite in oral biofilm control [41,44].

4.3. Probiotics

Probiotics are bacteria that are able to live and perform cell proliferation for growth [37,109]. Probiotic formulations should, at least, contain 106 CFU mL−1 of live probiotic bacteria when being used [110]. As oral care products such as toothpastes and mouth washes are classified as cosmetic products in the EU, the use of living microorganisms can be critical [111]. However, other product classes are available such as medical devices. Probiotics, such as Lacobacilli spp., have been shown to positively influence caries biofilms [112,113]. As bacteria are producing so-called bacteriocins, Lactobacilli strains that are not cariogenic, but fighting acidogenic bacteria, can be used for oral care formulations. It is important to note that the use, as with all other oral care products, needs to be on a regular basis so that the oral homeostasis can be achieved [14].

4.4. Summary

Oral biofilms are ubiquitous and can develop in every individual. While change of the diet to less fermentable carbohydrates and the mechanical removal of dental plaque will reduce the potential of those biofilms to become cariogenic, active ingredients in oral care formulations can also help to reduce the cariogenicity of the biofilm in various ways, including but not limited to buffering the acidity. Scientific studies show biomimetic approaches using calcium- and carbonate-containing actives as promising ingredients that can be used to change the properties of cariogenic biofilms.

5. Conclusions

Cariogenic biofilms produce organic acids that can demineralize the tooth mineral. Consequently, the mechanical removal of these biofilms is essential. However, a complete removal of dental plaque is not possible in the daily oral care routine; therefore, active ingredients are needed that can incorporate into biofilms, to help in reducing the adverse effects of the acids produced by the bacteria. Basic amino acids have only a limited buffering effect due to its marginal adhesion to the tooth surface and rapid clearance from the oral cavity. In contrast to this, oral care formulations with buffering agents such as calcium carbonate and/or (carbonated) hydroxyapatite can interact with the tooth surface and have the potential to reduce the demineralization by cariogenic biofilms due to their buffering properties and potential calcium and phosphate ion release.

Author Contributions

Conceptualization, F.M., J.E., M.E., B.T.A. and B.S.; methodology, F.M., J.E., M.E.; validation, B.T.A. and B.S.; writing—original draft preparation, F.M. and J.E.; writing—review and editing, F.M., J.E., M.E., B.T.A. and B.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not Applicable.

Informed Consent Statement

Not Applicable.

Data Availability Statement

Not Applicable.

Conflicts of Interest

The authors declare that there is no conflict of interest.

References

  1. Flemming, H.C.; Wingender, J.; Szewzyk, U.; Steinberg, P.; Rice, S.A.; Kjelleberg, S. Biofilms: An emergent form of bacterial life. Nat. Rev. Microbiol. 2016, 14, 563–575. [Google Scholar] [CrossRef] [PubMed]
  2. Camarinha-Silva, A.; Jauregui, R.; Pieper, D.H.; Wos-Oxley, M.L. The temporal dynamics of bacterial communities across human anterior nares. Environ. Microbiol. Rep. 2012, 4, 126–132. [Google Scholar] [CrossRef] [PubMed]
  3. Caputo, M.; Zoch-Lesniak, B.; Karch, A.; Vital, M.; Meyer, F.; Klawonn, F.; Baillot, A.; Pieper, D.H.; Mikolajczyk, R.T. Bacterial community structure and effects of picornavirus infection on the anterior nares microbiome in early childhood. BMC Microbiol. 2019, 19, 1. [Google Scholar] [CrossRef] [Green Version]
  4. Sultan, A.S.; Kong, E.F.; Rizk, A.M.; Jabra-Rizk, M.A. The oral microbiome: A Lesson in coexistence. PLoS Pathog. 2018, 14, e1006719. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Bianconi, E.; Piovesan, A.; Facchin, F.; Beraudi, A.; Casadei, R.; Frabetti, F.; Vitale, L.; Pelleri, M.C.; Tassani, S.; Piva, F.; et al. An estimation of the number of cells in the human body. Ann. Hum. Biol. 2013, 40, 463–471. [Google Scholar] [CrossRef]
  6. Sender, R.; Fuchs, S.; Milo, R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016, 14, e1002533. [Google Scholar] [CrossRef] [Green Version]
  7. Wan, A.K.; Seow, W.K.; Walsh, L.J.; Bird, P.; Tudehope, D.L.; Purdie, D.M. Association of Streptococcus mutans infection and oral developmental nodules in pre-dentate infants. J. Dent. Res. 2001, 80, 1945–1948. [Google Scholar] [CrossRef]
  8. Ravn, I.; Dige, I.; Meyer, R.L.; Nyvad, B. Colonization of the oral cavity by probiotic bacteria. Caries Res. 2012, 46, 107–112. [Google Scholar] [CrossRef]
  9. Teng, F.; Yang, F.; Huang, S.; Bo, C.; Xu, Z.Z.; Amir, A.; Knight, R.; Ling, J.; Xu, J. Prediction of Early Childhood Caries via Spatial-Temporal Variations of Oral Microbiota. Cell Host Microbe 2015, 18, 296–306. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Fejerskov, O.; Kidd, E. Dental Caries: The Disease and Its Clinical Management; Wiley: Hoboken, NJ, USA, 2009. [Google Scholar]
  11. Lynch, R.J.; Smith, S.R. Remineralization agents–new and effective or just marketing hype? Adv. Dent. Res. 2012, 24, 63–67. [Google Scholar] [CrossRef]
  12. Kim, K.; Choi, S.; Chang, J.; Kim, S.M.; Kim, S.J.; Kim, R.J.-Y.; Cho, H.-J.; Park, S.M. Severity of dental caries and risk of coronary heart disease in middle-aged men and women: A population-based cohort study of Korean adults, 2002–2013. Sci. Rep. 2019, 9, 10491. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Dewhirst, F.E.; Chen, T.; Izard, J.; Paster, B.J.; Tanner, A.C.; Yu, W.H.; Lakshmanan, A.; Wade, W.G. The human oral microbiome. J. Bacteriol. 2010, 192, 5002–5017. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Meyer, F.; Enax, J. Die Mundhöhle als Ökosystem. Biol. Unserer Zeit 2018, 48, 62–68. [Google Scholar] [CrossRef]
  15. Verma, D.; Garg, P.K.; Dubey, A.K. Insights into the human oral microbiome. Arch. Microbiol. 2018, 200, 525–540. [Google Scholar] [CrossRef] [PubMed]
  16. Zijnge, V.; van Leeuwen, M.B.; Degener, J.E.; Abbas, F.; Thurnheer, T.; Gmur, R.; Harmsen, H.J. Oral biofilm architecture on natural teeth. PLoS ONE 2010, 5, e9321. [Google Scholar] [CrossRef] [Green Version]
  17. Flemming, H.C.; Neu, T.R.; Wozniak, D.J. The EPS matrix: The “house of biofilm cells”. J. Bacteriol. 2007, 189, 7945–7947. [Google Scholar] [CrossRef] [Green Version]
  18. Sztajer, H.; Szafranski, S.P.; Tomasch, J.; Reck, M.; Nimtz, M.; Rohde, M.; Wagner-Dobler, I. Cross-feeding and interkingdom communication in dual-species biofilms of Streptococcus mutans and Candida albicans. ISME J. 2014, 8, 2256–2271. [Google Scholar] [CrossRef] [Green Version]
  19. Reck, M.; Tomasch, J.; Wagner-Döbler, I. The Alternative Sigma Factor SigX Controls Bacteriocin Synthesis and Competence, the Two Quorum Sensing Regulated Traits in Streptococcus mutans. PLoS Genet. 2015, 11, e1005353. [Google Scholar] [CrossRef]
  20. Eick, S. Biofilms. Monogr. Oral Sci. 2021, 29, 1–11. [Google Scholar] [CrossRef]
  21. Jakubovics, N.S.; Goodman, S.D.; Mashburn-Warren, L.; Stafford, G.P.; Cieplik, F. The dental plaque biofilm matrix. Periodontol. 2000 2021, 86, 32–56. [Google Scholar] [CrossRef]
  22. Edgar, W.; Dawes, C.; O’Mullane, D. Saliva and Oral Health; Stephen Hancocks Limited: London, UK, 2012. [Google Scholar]
  23. Eriksson, L.; Lif Holgerson, P.; Johansson, I. Saliva and tooth biofilm bacterial microbiota in adolescents in a low caries community. Sci. Rep. 2017, 7, 5861. [Google Scholar] [CrossRef] [Green Version]
  24. Preda, C.; Butera, A.; Pelle, S.; Pautasso, E.; Chiesa, A.; Esposito, F.; Oldoini, G.; Scribante, A.; Genovesi, A.M.; Cosola, S. The Efficacy of Powered Oscillating Heads vs. Powered Sonic Action Heads Toothbrushes to Maintain Periodontal and Peri-Implant Health: A Narrative Review. Int. J. Environ. Res. Public Health 2021, 18, 1468. [Google Scholar] [CrossRef]
  25. Daly, S.; Seong, J.; Newcombe, R.; Davies, M.; Nicholson, J.; Edwards, M.; West, N. A randomised clinical trial to determine the effect of a toothpaste containing enzymes and proteins on gum health over 3 months. J. Dent. 2019, 80, S26–S32. [Google Scholar] [CrossRef]
  26. Velusamy, S.K.; Markowitz, K.; Fine, D.H.; Velliyagounder, K. Human lactoferrin protects against Streptococcus mutans-induced caries in mice. Oral Dis. 2016, 22, 148–154. [Google Scholar] [CrossRef]
  27. Krupińska, A.M.; Bogucki, Z. Clinical aspects of the use of lactoferrin in dentistry. J. Oral Biosci. 2021. [Google Scholar] [CrossRef] [PubMed]
  28. Meyer, F.; Enax, J. Hydroxyapatite in Oral Biofilm Management. Eur. J. Dent. 2019, 13, 287–290. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Meyer, F.; Amaechi, B.T.; Fabritius, H.O.; Enax, J. Overview of calcium phosphates used in biomimetic oral care. Open Dent. J. 2018, 12, 406–423. [Google Scholar] [CrossRef] [PubMed]
  30. Enax, J.; Fabritius, H.O.; Fabritius-Vilpoux, K.; Amaechi, B.T.; Meyer, F. Modes of Action and Clinical Efficacy of Particulate Hydroxyapatite in Preventive Oral Health Care − State of the Art. Open Dent. J. 2019, 13, 274–287. [Google Scholar] [CrossRef]
  31. Cieplik, F.; Rupp, C.M.; Hirsch, S.; Muehler, D.; Enax, J.; Meyer, F.; Hiller, K.-A.; Buchalla, W. Ca2+ release and buffering effects of synthetic hydroxyapatite following bacterial acid challenge. BMC Oral Health 2020, 20, 85. [Google Scholar] [CrossRef] [Green Version]
  32. Cardoso, A.-A.; de Sousa, E.-T.; Steiner-Oliveira, C.; Parisotto, T.-M.; Nobre-Dos-Santos, M. A high salivary calcium concentration is a protective factor for caries development during orthodontic treatment. J. Clin. Exp. Dent. 2020, 12, e209–e214. [Google Scholar] [CrossRef]
  33. Farooq, I.; Bugshan, A. The role of salivary contents and modern technologies in the remineralization of dental enamel: A review [version 1; peer review: Awaiting peer review]. F1000Research 2020, 9. [Google Scholar] [CrossRef]
  34. Duke, S.A.; Rees, D.A.; Forward, G.C. Increased plaque calcium and phosphorus concentrations after using a calcium carbonate toothpaste containing calcium glycerophosphate and sodium monofluorophosphate. Pilot study. Caries Res. 1979, 13, 57–59. [Google Scholar] [CrossRef]
  35. Naylor, M.N.; Glass, R.L. A 3-year clinical trial of calcium carbonate dentifrice containing calcium glycerophosphate and sodium monofluorophosphate. Caries Res. 1979, 13, 39–46. [Google Scholar] [CrossRef] [PubMed]
  36. Schlagenhauf, U.; Jakob, L.; Eigenthaler, M.; Segerer, S.; Jockel-Schneider, Y.; Rehn, M. Regular consumption of Lactobacillus reuteri-containing lozenges reduces pregnancy gingivitis: An RCT. J. Clin. Periodontol. 2016, 43, 948–954. [Google Scholar] [CrossRef] [Green Version]
  37. Schlagenhauf, U.; Rehder, J.; Gelbrich, G.; Jockel-Schneider, Y. Consumption of Lactobacillus reuteri-containing lozenges improves periodontal health in navy sailors at sea: A randomized controlled trial. J. Periodontol. 2020, 91, 1328–1338. [Google Scholar] [CrossRef] [Green Version]
  38. Philip, N. State of the Art Enamel Remineralization Systems: The Next Frontier in Caries Management. Caries Res. 2019, 53, 284–295. [Google Scholar] [CrossRef]
  39. Limeback, H. Protection of the Dentition. In Comprehensive Preventive Dentistry; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2012; pp. 195–210. [Google Scholar] [CrossRef]
  40. Epple, M.; Meyer, F.; Enax, J. A Critical Review of Modern Concepts for Teeth Whitening. Dent. J. 2019, 7, 79. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Kensche, A.; Holder, C.; Basche, S.; Tahan, N.; Hannig, C.; Hannig, M. Efficacy of a mouthrinse based on hydroxyapatite to reduce initial bacterial colonisation in situ. Arch. Oral Biol. 2017, 80, 18–26. [Google Scholar] [CrossRef]
  42. Nobre, C.M.G.; Pütz, N.; König, B.; Rupf, S.; Hannig, M. Modification of in situ Biofilm Formation on Titanium by a Hydroxyapatite Nanoparticle-Based Solution. Front. Bioing. Biotech. 2020, 8, 1384. [Google Scholar] [CrossRef]
  43. Nobre, C.M.G.; Pütz, N.; Hannig, M. Adhesion of Hydroxyapatite Nanoparticles to Dental Materials under Oral Conditions. Scanning 2020, 2020, 6065739. [Google Scholar] [CrossRef] [PubMed]
  44. Hannig, C.; Basche, S.; Burghardt, T.; Al-Ahmad, A.; Hannig, M. Influence of a mouthwash containing hydroxyapatite microclusters on bacterial adherence in situ. Clin. Oral Investig. 2013, 17, 805–814. [Google Scholar] [CrossRef]
  45. Arweiler, N.B. Oral Mouth Rinses against Supragingival Biofilm and Gingival Inflammation. Monogr. Oral Sci. 2021, 29, 91–97. [Google Scholar] [CrossRef]
  46. Cieplik, F.; Kara, E.; Muehler, D.; Enax, J.; Hiller, K.-A.; Maisch, T.; Buchalla, W. Antimicrobial efficacy of alternative compounds for use in oral care toward biofilms from caries-associated bacteria in vitro. Microbiol. Open 2018, 8, e00695. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Trautmann, S.; Künzel, N.; Fecher-Trost, C.; Barghash, A.; Schalkowsky, P.; Dudek, J.; Delius, J.; Helms, V.; Hannig, M. Deep Proteomic Insights into the Individual Short-Term Pellicle Formation on Enamel-An In Situ Pilot Study. Proteom. Clin. Appl. 2020, 14, e1900090. [Google Scholar] [CrossRef] [PubMed]
  48. Schulz, A.; Lang, R.; Behr, J.; Hertel, S.; Reich, M.; Kümmerer, K.; Hannig, M.; Hannig, C.; Hofmann, T. Targeted metabolomics of pellicle and saliva in children with different caries activity. Sci. Rep. 2020, 10, 697. [Google Scholar] [CrossRef] [Green Version]
  49. Hannig, C.; Hannig, M.; Kensche, A.; Carpenter, G. The mucosal pellicle–An underestimated factor in oral physiology. Arch. Oral Biol. 2017, 80, 144–152. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Lynge Pedersen, A.M.; Belstrøm, D. The role of natural salivary defences in maintaining a healthy oral microbiota. J. Dent. 2019, 80 (Suppl. S1), S3–S12. [Google Scholar] [CrossRef]
  51. Xu, X.; He, J.; Xue, J.; Wang, Y.; Li, K.; Zhang, K.; Guo, Q.; Liu, X.; Zhou, Y.; Cheng, L.; et al. Oral cavity contains distinct niches with dynamic microbial communities. Environ. Microbiol. 2015, 17, 699–710. [Google Scholar] [CrossRef]
  52. Boisen, G.; Davies, J.R.; Neilands, J. Acid tolerance in early colonizers of oral biofilms. BMC Microbiol. 2021, 21, 45. [Google Scholar] [CrossRef] [PubMed]
  53. Taubman, M.A.; Nash, D.A. The scientific and public-health imperative for a vaccine against dental caries. Nat. Rev. Immunol. 2006, 6, 555–563. [Google Scholar] [CrossRef]
  54. Vacca Smith, A.M.; Bowen, W.H. In situ studies of pellicle formation on hydroxyapatite discs. Arch. Oral Biol. 2000, 45, 277–291. [Google Scholar] [CrossRef]
  55. Kolenbrander, P.E.; Andersen, R.N.; Blehert, D.S.; Egland, P.G.; Foster, J.S.; Palmer, R.J. Communication among Oral Bacteria. Microbiol. Molec.Rev. 2002, 66, 486. [Google Scholar] [CrossRef] [Green Version]
  56. Deng, Z.-L.; Szafrański, S.P.; Jarek, M.; Bhuju, S.; Wagner-Döbler, I. Dysbiosis in chronic periodontitis: Key microbial players and interactions with the human host. Sci. Rep. 2017, 7, 3703. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Szafrański, S.P.; Deng, Z.-L.; Tomasch, J.; Jarek, M.; Bhuju, S.; Rohde, M.; Sztajer, H.; Wagner-Döbler, I. Quorum sensing of Streptococcus mutans is activated by Aggregatibacter actinomycetemcomitans and by the periodontal microbiome. BMC Genom. 2017, 18, 238. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Lemme, A.; Gröbe, L.; Reck, M.; Tomasch, J.; Wagner-Döbler, I. Subpopulation-specific transcriptome analysis of competence-stimulating-peptide-induced Streptococcus Mutans. J Bacteriol. 2011, 193, 1863. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Huang, R.; Li, M.; Gregory, R.L. Bacterial interactions in dental biofilm. Virulence 2011, 2, 435–444. [Google Scholar] [CrossRef] [PubMed]
  60. Koo, H.; Falsetta, M.L.; Klein, M.I. The Exopolysaccharide Matrix: A Virulence Determinant of Cariogenic Biofilm. J. Dent. Res. 2013, 92, 1065–1073. [Google Scholar] [CrossRef] [Green Version]
  61. Anderson, A.C.; Rothballer, M.; Altenburger, M.J.; Woelber, J.P.; Karygianni, L.; Lagkouvardos, I.; Hellwig, E.; Al-Ahmad, A. In-vivo shift of the microbiota in oral biofilm in response to frequent sucrose consumption. Sci. Rep. 2018, 8, 14202. [Google Scholar] [CrossRef] [PubMed]
  62. Adler, C.J.; Browne, G.V.; Sukumar, S.; Hughes, T. Evolution of the Oral Microbiome and Dental Caries. Curr. Oral Health Rep. 2017, 4, 264–269. [Google Scholar] [CrossRef] [Green Version]
  63. Moye, Z.D.; Zeng, L.; Burne, R.A. Fueling the caries process: Carbohydrate metabolism and gene regulation by Streptococcus mutans. J. Oral Microbiol. 2014, 6, 24878. [Google Scholar] [CrossRef] [Green Version]
  64. Du, Q.; Fu, M.; Zhou, Y.; Cao, Y.; Guo, T.; Zhou, Z.; Li, M.; Peng, X.; Zheng, X.; Li, Y.; et al. Sucrose promotes caries progression by disrupting the microecological balance in oral biofilms: An in vitro study. Sci. Rep. 2020, 10, 2961. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Roopa, K.; Pathak, S.; Poornima, P.; Neena, I. White spot lesions: A literature review. J. Paed. Dent. 2015, 3, 1–7. [Google Scholar] [CrossRef]
  66. Astasov-Frauenhoffer, M.; Varenganayil, M.M.; Decho, A.W.; Waltimo, T.; Braissant, O. Exopolysaccharides regulate calcium flow in cariogenic biofilms. PLoS ONE 2017, 12, e0186256. [Google Scholar] [CrossRef] [Green Version]
  67. Leitao, T.J.; Cury, J.A.; Tenuta, L.M.A. Kinetics of calcium binding to dental biofilm bacteria. PLoS ONE 2018, 13, e0191284. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Valkenburg, C.; Slot, D.; Bakker, E.; van der Weijden, F. Does dentifrice use help to remove plaque? A systematic review. J. Clin. Periodontol. 2016, 43, 1050–1058. [Google Scholar] [CrossRef]
  69. Simon-Soro, A.; Tomas, I.; Cabrera-Rubio, R.; Catalan, M.D.; Nyvad, B.; Mira, A. Microbial geography of the oral cavity. J. Dent. Res. 2013, 92, 616–621. [Google Scholar] [CrossRef]
  70. Loveren, C.V. Toothpastes; Karger: Basel, Switzerland, 2013; Volume 23. [Google Scholar]
  71. Epple, M.; Enax, J. Moderne Zahnpflege aus chemischer Sicht. Chem. Unserer Zeit 2018, 4, 218–228. [Google Scholar] [CrossRef]
  72. Marsh, P.D. Contemporary perspective on plaque control. Br. Dent. J. 2012, 212, 601–606. [Google Scholar] [CrossRef] [Green Version]
  73. Marsh, P.D. Controlling the oral biofilm with antimicrobials. J. Dent. 2010, 38 (Suppl. S1), S11–S15. [Google Scholar] [CrossRef]
  74. Beyer, A.; Dalton, M.; Doll, K.; Winkel, A.; Stumpp, N.S.; Stiesch, M. In Vitro Antibacterial Effectiveness of a Naturopathic Oral Care Product on Oral Pathogens. Oral Health Prev. Dent. 2020, 18, 625–632. [Google Scholar] [CrossRef]
  75. Epple, M. Review of potential health risks associated with nanoscopic calcium phosphate. Acta Biomater. 2018, 77, 1–14. [Google Scholar] [CrossRef]
  76. Humphrey, S.P.; Williamson, R.T. A review of saliva: Normal composition, flow, and function. J. Prosthet. Dent. 2001, 85, 162–169. [Google Scholar] [CrossRef]
  77. Wolff, M.S.; Schenkel, A.B. The Anticaries Efficacy of a 1.5% Arginine and Fluoride Toothpaste. Adv. Dent. Res. 2018, 29, 93–97. [Google Scholar] [CrossRef] [PubMed]
  78. Nascimento, M.M. Potential Uses of Arginine in Dentistry. Adv. Dent. Res. 2018, 29, 98–103. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. Duke, S.A. Effect of chalk-based toothpaste on pH changes in dental plaque in vivo. Caries Res. 1986, 20, 278–283. [Google Scholar] [CrossRef] [PubMed]
  80. Duke, S.A. Effect induced by a chalk-based toothpaste on the pH changes of plaque challenged by a high sugar diet over an 8-hour period. Caries Res. 1986, 20, 381–384. [Google Scholar] [CrossRef] [PubMed]
  81. Grychtol, S.; Basche, S.; Hannig, M.; Hannig, C. Effect of CPP/ACP on Initial Bioadhesion to Enamel and Dentin in situ. Sci. World J. 2014, 2014, 512682. [Google Scholar] [CrossRef]
  82. Vogel, G.L.; Zhang, Z.; Carey, C.M.; Ly, A.; Chow, L.C.; Proskin, H.M. Composition of plaque and saliva following use of an alpha-tricalcium-phosphate-containing chewing gum and a subsequent sucrose challenge. J. Dent. Res. 2000, 79, 58–62. [Google Scholar] [CrossRef] [PubMed]
  83. Fitch, C.A.; Platzer, G.; Okon, M.; Garcia-Moreno, B.E.; McIntosh, L.P. Arginine: Its pKa value revisited. Protein Sci. 2015, 24, 752–761. [Google Scholar] [CrossRef] [Green Version]
  84. Hayashi, K.; Matsuda, T.; Takeyama, T.; Hino, T. Solubilities Studies of Basic Amino Acids. Agric. Biol. Chem. 1966, 30, 378–384. [Google Scholar] [CrossRef]
  85. Grimble, G.K. Adverse gastrointestinal effects of arginine and related amino acids. J. Nutr. 2007, 137, 1693s–1701s. [Google Scholar] [CrossRef] [Green Version]
  86. Olsen, I.; Singhrao, S.K.; Potempa, J. Citrullination as a plausible link to periodontitis, rheumatoid arthritis, atherosclerosis and Alzheimer’s disease. J. Oral Microbiol. 2018, 10, 1487742. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Hernández-Castañeda, A.A.; Aranzazu-Moya, G.C.; Mora, G.M.; Queluz, D.d.P. Chemical salivary composition and its relationship with periodontal disease and dental calculus. Bras. J. Oral Sci. 2015, 14, 159–165. [Google Scholar] [CrossRef] [Green Version]
  88. Schiller, C.; Epple, M. Carbonated calcium phosphates are suitable pH-stabilising fillers for biodegradable polyesters. Biomaterials 2003, 24, 2037–2043. [Google Scholar] [CrossRef]
  89. Shaw, L.; Murray, J.J.; Burchell, C.K.; Best, J.S. Calcium and Phosphorus Content of Plaque and Saliva in Relation to Dental Caries. Caries Res. 1983, 17, 543–548. [Google Scholar] [CrossRef]
  90. Enax, J.; Fabritius, H.-O.; Amaechi, B.T.; Meyer, F. Hydroxylapatit als biomimetischer Wirkstoff für die Remineralisation von Zahnschmelz und Dentin. ZWR-Das Dtsch. Zahnärzteblatt 2020, 129, 277–283. [Google Scholar] [CrossRef]
  91. Lelli, M.; Marchetti, M.; Foltran, I.; Roveri, N.; Putignano, A.; Procaccini, M.; Orsini, G.; Mangani, F. Remineralization and repair of enamel surface by biomimetic Zn-carbonate hydroxyapatite containing toothpaste: A comparative in vivo study. Front. Physiol. 2014, 5, 333. [Google Scholar] [CrossRef] [Green Version]
  92. Fabritius-Vilpoux, K.; Enax, J.; Herbig, M.; Raabe, D.; Fabritius, H.-O. Quantitative Affinity Parameters of Synthetic Hydroxyapatite and Enamel Surfaces in vitro. Bioinspired Biomim. Nanobiomaterials 2019, 8, 141–153. [Google Scholar] [CrossRef] [Green Version]
  93. Sarembe, S.; Enax, J.; Morawietz, M.; Kiesow, A.; Meyer, F. In Vitro Whitening Effect of a Hydroxyapatite-Based Oral Care Gel. Eur. J. Dent. 2020, 14, 335–341. [Google Scholar] [CrossRef]
  94. Sudradjat, H.; Meyer, F.; Loza, K.; Epple, M.; Enax, J. In Vivo Effects of a Hydroxyapatite-Based Oral Care Gel on the Calcium and Phosphorus Levels of Dental Plaque. Eur. J. Dent. 2020, 14, 206–211. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Amaechi, B.T.; AbdulAzees, P.A.; Okoye, L.O.; Meyer, F.; Enax, J. Comparison of hydroxyapatite and fluoride oral care gels for remineralization of initial caries: A pH-cycling study. BDJ Open 2020, 6, 9. [Google Scholar] [CrossRef] [PubMed]
  96. Scribante, A.; Farahani, M.; Marino, G.; Matera, C.; Baena, R.; Lanteri, V.; Butera, A. Biomimetic Effect of Nano-Hydroxyapatite in Demineralized Enamel before Orthodontic Bonding of Brackets and Attachments: Visual, Adhesion Strength, and Hardness in In Vitro Tests. BioMed Res. Int. 2020, 2020, 1–9. [Google Scholar] [CrossRef] [Green Version]
  97. Enax, J.; Epple, M. Die Charakterisierung von Putzkörpern in Zahnpasten. Dtsch. Zahnärztl. Z. 2018, 73, 116–124. [Google Scholar] [CrossRef]
  98. Eggert, F.; Neubert, R. In vitro investigation of the liberation of fluoride ions from toothpaste compounds in a permeation model. Eur. J. Pharm. Biopharm. 1999, 47, 169–173. [Google Scholar] [CrossRef]
  99. Amaechi, B.T.; AbdulAzees, P.A.; Alshareif, D.O.; Shehata, M.A.; Lima, P.P.d.C.S.; Abdollahi, A.; Kalkhorani, P.S.; Evans, V. Comparative efficacy of a hydroxyapatite and a fluoride toothpaste for prevention and remineralization of dental caries in children. BDJ Open 2019, 5, 18. [Google Scholar] [CrossRef]
  100. Schlagenhauf, U.; Kunzelmann, K.-H.; Hannig, C.; May, T.W.; Hösl, H.; Gratza, M.; Viergutz, G.; Nazet, M.; Schamberger, S.; Proff, P. Impact of a non-fluoridated microcrystalline hydroxyapatite dentifrice on enamel caries progression in highly caries-susceptible orthodontic patients: A randomized, controlled 6-month trial. J. Investig. Clin. Dent. 2019, 10, e12399. [Google Scholar] [CrossRef] [Green Version]
  101. Paszynska, E.; Pawinska, M.; Gawriolek, M.; Kaminska, I.; Otulakowska-Skrzynska, J.; Marczuk-Kolada, G.; Rzatowski, S.; Sokolowska, K.; Olszewska, A.; Schlagenhauf, U.; et al. Impact of a toothpaste with microcrystalline hydroxyapatite on the occurrence of early childhood caries: A 1-year randomized clinical trial. Sci. Rep. 2021, 11, 2650. [Google Scholar] [CrossRef]
  102. Hiller, K.-A.; Buchalla, W.; Grillmeier, I.; Neubauer, C.; Schmalz, G. In vitro effects of hydroxyapatite containing toothpastes on dentin permeability after multiple applications and ageing. Sci. Rep. 2018, 8, 4888. [Google Scholar] [CrossRef]
  103. Vano, M.; Derchi, G.; Barone, A.; Pinna, R.; Usai, P.; Covani, U. Reducing dentine hypersensitivity with nano-hydroxyapatite toothpaste: A double-blind randomized controlled trial. Clin. Oral Investig. 2017, 22, 313–320. [Google Scholar] [CrossRef] [PubMed]
  104. Steinert, S.; Zwanzig, K.; Doenges, H.; Kuchenbecker, J.; Meyer, F.; Enax, J. Daily Application of a Toothpaste with Biomimetic Hydroxyapatite and Its Subjective Impact on Dentin Hypersensitivity, Tooth Smoothness, Tooth Whitening, Gum Bleeding, and Feeling of Freshness. Biomimetics 2020, 5, 17. [Google Scholar] [CrossRef] [PubMed]
  105. Orsini, G.; Procaccini, M.; Manzoli, L.; Giuliodori, F.; Lorenzini, A.; Putignano, A. A double-blind randomized-controlled trial comparing the desensitizing efficacy of a new dentifrice containing carbonate/hydroxyapatite nanocrystals and a sodium fluoride/potassium nitrate dentifrice. J. Clin. Periodontol. 2010, 37, 510–517. [Google Scholar] [CrossRef] [PubMed]
  106. Hu, M.-L.; Zheng, G.; Zhang, Y.-D.; Yan, X.; Li, X.-C.; Lin, H. Effect of desensitizing toothpastes on dentine hypersensitivity: A systematic review and meta-analysis. J. Dent. 2018, 75, 12–21. [Google Scholar] [CrossRef]
  107. Hu, M.L.; Zheng, G.; Lin, H.; Yang, M.; Zhang, Y.D.; Han, J.M. Network meta-analysis on the effect of desensitizing toothpastes on dentine hypersensitivity. J. Dent. 2019, 88, 103170. [Google Scholar] [CrossRef]
  108. Jasmin, K.; Matthias, H.; Pia, W.; Sabine, B.; Birgit, L.; Norbert, P.; Anna, K.; Christian, H. Influence of pure fluorides and stannous ions on the initial bacterial colonization in situ. Sci. Rep. 2019, 9, 18499. [Google Scholar] [CrossRef] [Green Version]
  109. Bowen, D.M. Probiotics and Oral Health. Am. Dent. Hyg. Ass. 2013, 87, 5–9. [Google Scholar]
  110. Marinova, V.Y.; Rasheva, I.K.; Kizheva, Y.K.; Dermenzhieva, Y.D.; Hristova, P.K. Microbiological quality of probiotic dietary supplements. Biotechnol. Biotechnol. Equip. 2019, 33, 834–841. [Google Scholar] [CrossRef] [Green Version]
  111. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on Cosmetic Products. 2009. Available online: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:342:0059:0209:en:PDF (accessed on 27 July 2021).
  112. Söderling, E. Probiotics and Dental Caries Risk. In Comprehensive Preventive Dentistry; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2012; pp. 115–118. [Google Scholar] [CrossRef]
  113. Mahasneh, S.A.; Mahasneh, A.M. Probiotics: A Promising Role in Dental Health. Dent. J. 2017, 5, 26. [Google Scholar] [CrossRef] [Green Version]
Table
Table 1. Overview of buffering systems for use under physiological conditions. The optimum buffering conditions occur when the pH is at the pKa value.
Table 1. Overview of buffering systems for use under physiological conditions. The optimum buffering conditions occur when the pH is at the pKa value.
Buffer SystemspKa Values
B(OH)3/B(OH)4− (borate buffer)9.25
NH3/NH4+ (ammonium buffer)9.24
HPO42−/H2PO4− (phosphate buffer)7.21 (other pKa values 2.16; 12.32)
Citric acid/citrate3.13; 4.76; 6.4
Carbonic acid/hydrogen carbonate6.1
CH3COO−/CH3COOH4.76
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Meyer, F.; Enax, J.; Epple, M.; Amaechi, B.T.; Simader, B. Cariogenic Biofilms: Development, Properties, and Biomimetic Preventive Agents. Dent. J. 2021, 9, 88. https://0-doi-org.brum.beds.ac.uk/10.3390/dj9080088

AMA Style

Meyer F, Enax J, Epple M, Amaechi BT, Simader B. Cariogenic Biofilms: Development, Properties, and Biomimetic Preventive Agents. Dentistry Journal. 2021; 9(8):88. https://0-doi-org.brum.beds.ac.uk/10.3390/dj9080088

Chicago/Turabian Style

Meyer, Frederic, Joachim Enax, Matthias Epple, Bennett T. Amaechi, and Barbara Simader. 2021. "Cariogenic Biofilms: Development, Properties, and Biomimetic Preventive Agents" Dentistry Journal 9, no. 8: 88. https://0-doi-org.brum.beds.ac.uk/10.3390/dj9080088

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop